[Mixed dementia: a neuropathologic point od view]

Dina Zekry1, Charles Duyckaerts, Jean-Jacques Hauw

  • 1Laboratoire de neuropathologie, Hôpital de la Salpêtrière, Paris, France. dina.zekry@hcuge.ch

Insights

Distinguishing mixed dementia (MD) from Alzheimer's disease (AD) and vascular dementia (VaD) is challenging. This review covers neuropathological aspects of MD, a common elderly dementia, aiding diagnosis and treatment strategies.

Area of Science:

  • Neuropathology
  • Geriatric Medicine
  • Neurodegenerative Diseases

Context:

  • Alzheimer's disease (AD) and vascular dementia (VaD) are leading causes of dementia in the elderly.
  • Accurate differentiation between pure AD, VaD, and mixed dementia (MD) presents significant diagnostic challenges.
  • MD, involving co-existing AD and VaD pathologies, is highly prevalent in the elderly population.

Purpose:

  • To review the neuropathological underpinnings of mixed dementia (MD) in the elderly.
  • To highlight the diagnostic complexities and ongoing debates surrounding MD.
  • To underscore the importance of accurate MD diagnosis for epidemiological, preventive, and therapeutic advancements.

Summary:

  • Mixed dementia (MD) frequently occurs in the elderly, combining Alzheimer's disease (AD) and vascular dementia (VaD) pathologies.
  • Neuropathological studies confirm the high prevalence of MD, yet the relative contributions of degenerative and vascular lesions remain debated.
  • Accurate diagnosis of MD is critical for effective epidemiological assessment and the development of targeted therapeutic strategies.

Impact:

  • Improved understanding of MD neuropathology can refine diagnostic criteria and clinical assessments.
  • Enhanced diagnostic accuracy for MD will facilitate more precise epidemiological studies.
  • This review provides a foundation for developing tailored therapeutic approaches for mixed dementia, addressing a significant unmet clinical need.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...